SEC Form 4 · accession 0001209191-18-045573
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
IONIS PHARMACEUTICALS INC
10% Owner
Period of report
Aug 3, 2018
Accepted (ET)
Aug 6, 2018 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2018 | J | 1,597,571 | — | A | 65,712,116 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued in satisfaction of the Issuer's obligations to the Reporting Person pursuant to that certain License Agreement, dated March 14, 2018, between the Issuer and the Reporting Person.